Get started
Author

Laura Bonmassar

Observed names: Bonmassar, Laura, L BONMASSAR, L. Bonmassar, LAURA BONMASSAR
Observed institutions: University of Zurich, Slovak Academy of Sciences, Istituto Superiore di Sanità, Paul Scherrer Institute, Istituto Dermopatico dell'Immacolata, Istituti di Ricovero e Cura a Carattere Scientifico, Sapienza University of Rome
ORCID: 0000-0003-4875-9465
Observed ORCID: 0000-0003-4875-9465
OpenAlex ID: A5061789309
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
2019 · Simona Caporali, Adriana Amaro, et al. · Journal of Experimental & Clinical Cancer Research · 82
PDF
Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro
2011 · P. Correale, C. Botta, et al. · International Journal of Cancer · 77
PDF
Circulating tumor cells in colorectal cancer patients
2013 · Francesco Torino, Enzo Bonmassar, et al. · Cancer Treatment Reviews · 57
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase
2017 · Chiara Platella, Serena Guida, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 48
O6-(4-Bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro
2006 · M TURRIZIANI, P CAPORASO, et al. · Pharmacological Research · 39
Tolerance of human MSH2 +/− lymphoblastoid cells to the methylating agent temozolomide
2001 · Giancarlo Marra, Stefania D'Atri, et al. · Proceedings of the National Academy of Sciences · 39
Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
2017 · Simona Caporali, Ester Alvino, et al. · Oncotarget · 29
PDF
Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
2008 · Salvatore P Prete, Mario Turriziani, et al. · Journal of Experimental & Clinical Cancer Research · 22
PDF
Triazene Compounds in the Treatment of Acute Myeloid Leukemia: A Short Review and a Case Report
2013 · L. Bonmassar, F. Marchesi, et al. · Current Medicinal Chemistry · 19
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
2022 · Lauretta Levati, Cristian Bassi, et al. · Cancers · 15
PDF
Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro
2015 · GIORGIA CIOCCOLONI, LAURA BONMASSAR, et al. · International Journal of Oncology · 14
PDF
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
2024 · Lauretta Levati, Claudio Tabolacci, et al. · Journal of Experimental & Clinical Cancer Research · 12
PDF
The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro
2013 · Riccardo Adamo, Alessandro Comandini, et al. · Journal of Experimental & Clinical Cancer Research · 12
PDF
DNA Repair Enzymes and Cytotoxic Effects of Temozolomide: Comparative Studies Between Tumor Cells and Normal Cells of the Immune System
2003 · E. Pagani, R. Pepponi, et al. · Journal of Chemotherapy · 10
Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes
2011 · Angelo Aquino, Grazia Graziani, et al. · Clinical and Developmental Immunology · 9
PDF
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors
2023 · Federica Ruffini, Claudia Ceci, et al. · Pharmacological Research · 8
PDF
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
2020 · Maria Grazia Narducci, Anna Tosi, et al. · Frontiers in Immunology · 8
PDF
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells
2002 · Angelo Aquino, Salvatore Pasquale Prete, et al. · International Journal of Cancer · 7
A Novel Method for Monitoring Response to Chemotherapy Based on the Detection of Circulating Cancer Cells: A Case Report
2002 · A. Aquino, S.P. Prete, et al. · Journal of Chemotherapy · 7
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
2010 · Laura Bonmassar, Emanuela Fossile, et al. · PubMed · 5
BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression
2006 · Salvatore Pasquale Prete, Anna Giuliani, et al. · International Immunopharmacology · 5
A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro
2005 · Isabella Faraoni, Andrea Cottarelli, et al. · Journal of Immunological Methods · 2
Preclinical Studies on Detection of Circulating Melanoma Cells in Patients: Telomerase as a Recognition Marker of Malignancy
2004 · L. Bonmassar, M.C. Massara, et al. · Journal of Chemotherapy · 2
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases
2026 · Giulia Salvatore, Ylenia Aura Minafò, et al. · Frontiers in Immunology · 1
PDF
Abstract 474: Alterations of micro-RNAs are associated with melanoma resistance to BRAF inhibitors: Role of miR-126
2018 · Simona Caporali, Lauretta Levati, et al. · Cancer Research · 1
Works count: 43
Citation count: 532
H-index: 12
I10-index: 14
Year
Topic
Type